Wells Fargo raised the firm’s price target on Solventum (SOLV) to $75 from $73 and keeps an Equal Weight rating on the shares. The Q4 beat was largely expected by the Street and 2025 guidance calls for 1%-2% revenue growth, while EPS guide brackets consensus, the firm says. Up next, Solventum will host an investor day on March 20 where Wells expects management to provide an LRP.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum price target raised to $84 from $75 at Piper Sandler
- Solventum Corporation Reports Strong Q4 2024 Results
- Solventum reports Q4 EPS $1.41, consensus $1.31
- Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $6.59
- Cautious Hold Rating on Solventum Corporation Amid Strategic Sale and Debt Uncertainties